Pyxis Oncology, Inc. (PYXS) vs Tonix Pharmaceuticals Holding Corp. (TNXP)
A side-by-side comparison of Pyxis Oncology, Inc. and Tonix Pharmaceuticals Holding Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
PYXS
Pyxis Oncology, Inc.
$2.02HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
TNXP
Tonix Pharmaceuticals Holding Corp.
$7.70HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — PYXS vs TNXP
growth of $100 · dividends reinvested · last 5yPYXS -83.0% (-29.9%/yr)TNXP -100.0% (-87.3%/yr)PYXS compounded faster over this window
Log scale — wide-divergence pair
PYXS TNXP
PYXS vs TNXP: by the numbers
- •PYXS is the larger company ($128M vs $123M market cap).
- •Both run net losses; TNXP's is the smaller (-548.64% vs -803.83% net margin).
Metrics side by side
Valuation
| Metric | PYXS | TNXP |
|---|---|---|
| P/S ratio | 11.59 | 4.21 |
| P/B ratio | 11.19 | 0.55 |
Profitability
| Metric | PYXS | TNXP |
|---|---|---|
| Gross margin | 82.77% | 34.65% |
| Operating margin | -609.18% | -959.05% |
| Net margin | -803.83% | -548.64% |
| ROE | -775.59% | -71.83% |
| ROIC | -314.66% | -74.08% |
Growth (annualized)
| Metric | PYXS | TNXP |
|---|---|---|
| Total return CAGR (5Y) | N/A | -87.55% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.